Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 56858201000001110 | Canakinumab (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 56858301000001118 | Canakinumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Canakinumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Canakinumab 150mg powder for solution for injection vials | Has specific active ingredient | False | Canakinumab | Inferred relationship | Existential restriction modifier | |
| Ilaris 150mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) | Has specific active ingredient | False | Canakinumab | Inferred relationship | Existential restriction modifier | |
| Canakinumab 150mg powder for solution for injection vials 1 vial | Has specific active ingredient | False | Canakinumab | Inferred relationship | Existential restriction modifier | |
| Ilaris 150mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial | Has specific active ingredient | False | Canakinumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR